Search

Your search keyword '"Bergamaschi, Roberto"' showing total 1,565 results

Search Constraints

Start Over You searched for: Author "Bergamaschi, Roberto" Remove constraint Author: "Bergamaschi, Roberto"
1,565 results on '"Bergamaschi, Roberto"'

Search Results

151. Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register

153. A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis

154. Confirmed disability progression as a marker of permanent disability in multiple sclerosis

155. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

156. Confirmed disability progression as a marker of permanent disability in multiple sclerosis.

157. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

159. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

160. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

161. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

163. Correction to: The Italian multiple sclerosis register

164. Comparing the natural history of pediatric multiple sclerosis with onset before or after pubertal age (P1-5.005)

165. Trajectories of disability and relapse-rate in naïve patients on oral drugs: results from the Italian Multiple Sclerosis Register (P17-4.003)

166. A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS)

167. Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study

168. sj-docx-1-msj-10.1177_13524585221084577 – Supplemental material for Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

169. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study

170. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]

171. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

173. Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis

174. Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy

175. Repeat liver resections from colorectal metastasis

183. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEQ-IT)

184. Progression independent of relapse activity in early multiple sclerosis patients

185. Comparative effectiveness of early intensive or escalation treatment strategies on long term disability trajectories in relapsing multiple sclerosis patients

186. Long-term disability progression in childhood and adolescent onset multiple sclerosis patients

187. In brief

189. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)

192. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

193. Defining reliable disability outcomes in multiple sclerosis

194. Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

195. Association of Latitude and Exposure to Ultraviolet B Radiation with Severity of Multiple Sclerosis

196. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

199. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

200. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

Catalog

Books, media, physical & digital resources